Showing results (221-230 of 324) with videos related to
Sort By:
Pageof 33
Cancer Immunology Research|July 29, 2015
Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case ReportIsabella C Glitza, Cara Haymaker, Chantale Bernatchez, et al.Journal of Oncology Research and Therapy|March 14, 2025
Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human CancersAhmad A Tarhini, Dale Hedges, Aik Choon Tan, et al.Nature Reviews. Clinical Oncology|September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicitiesSattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanomaMark E Dudley, John R Wunderlich, James C Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss MelanomaWeiyi Peng, Leila J Williams, Chunyu Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2018
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor ModelSharareh Niknam, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.Nature Medicine|March 5, 2013
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletionYared Hailemichael, Zhimin Dai, Nina Jaffarzad, et al.Cancer Immunology Research|June 21, 2017
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune ToxicityJungsun Park, Amjad H Talukder, Seon A Lim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapyRichard W Joseph, Vijay R Peddareddigari, Ping Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2003
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaGiao Q Phan, James C Yang, Richard M Sherry, et al.Pageof 33